✦ LIBER ✦

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

✍ Scribed by Carina Roth; Brigitte Rack; Volkmar Müller; Wolfgang Janni; Klaus Pantel; Heidi Schwarzenbach

Book ID: 119915580
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 420 KB
Volume: 12
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr2766

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating microRNAs in plasma as early

Circulating microRNAs in plasma as early detection markers for breast cancer

✍ Katarina Cuk; Manuela Zucknick; Jörg Heil; Dharanija Madhavan; Sarah Schott; And 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 535 KB

Detection of circulating tumor cells in

Detection of circulating tumor cells in peripheral blood of patients with primary and metastatic breast cancer

✍ N. Fersis; Deckwart; A. Leitz; J. Rom; V. Zieglschmid; O. Böcher; M. Eichbaum; B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Circulating microRNA-92a and microRNA-21

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

✍ Haiyan Si, Xiaoming Sun, Yingjian Chen, Yuan Cao, Shimin Chen, Huanchun Wang, Ch 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 331 KB

Detection of circulating tumor cells in

Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker

✍ Hui Zhou; Jun-Ming Guo; Yan-Ru Lou; Xin-Jun Zhang; Fa-De Zhong; Zhen Jiang; Jia 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 455 KB

Flow cytometric assessment of monocyte a

Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer

✍ David Goodale; Carolina Phay; Wendy Brown; Leslie Gray-Statchuk; Patricia Furlon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Alternating chemotherapy regimens for pa

Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics

✍ David T. Kiang; B. J. Kennedy; Jerry Younger; Michael C. Perry; Albert Schilling 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Background. Chemotherapy is most effective when applied during the biologically active stage of tumor cells. According to the authors' previous tumor marker kinetic study, methotrexate plus 5-fluorouracil (MF) was found to yield either a cytolytic effect in an MF-sensitive tumor cell population or a